Women's knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the COVID-19 era in a sample of them: COMEM-GSM study

Abstract Objective To study knowledge regarding genitourinary syndrome of menopause (GSM) and the treatments for it and to analyze treatment adherence during the COVID-19 confinement. Methods Multi-center observational study including women between 35 and 75 years. An extension study of treatment ad...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Laura Baquedano Mainar, Sonia Sánchez Méndez, Peña Dieste Pérez, Mónica Hernández Aragón, Nicolás Mendoza Ladrón de Guevara, the COMEM Study Spanish investigators
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/11e1ec07cc8c464f813bf3cdc08515c2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:11e1ec07cc8c464f813bf3cdc08515c2
record_format dspace
spelling oai:doaj.org-article:11e1ec07cc8c464f813bf3cdc08515c22021-12-05T12:08:23ZWomen's knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the COVID-19 era in a sample of them: COMEM-GSM study10.1186/s12905-021-01548-21472-6874https://doaj.org/article/11e1ec07cc8c464f813bf3cdc08515c22021-11-01T00:00:00Zhttps://doi.org/10.1186/s12905-021-01548-2https://doaj.org/toc/1472-6874Abstract Objective To study knowledge regarding genitourinary syndrome of menopause (GSM) and the treatments for it and to analyze treatment adherence during the COVID-19 confinement. Methods Multi-center observational study including women between 35 and 75 years. An extension study of treatment adherence was conducted during the coronavirus pandemic between March and April 2020. Results A sample of 2355 women were included. Vaginal dryness was the most frequently identified symptom (74.3%). Lubricants were the best-known treatments (69.6%), followed by local estrogens (25.7%); 66% of the women did not speak to their gynecologist about sexuality. Comparative analyses were conducted according to age, menopausal status, type of menopause, place of residence, type of health care received and level of education. During the coronavirus confinement period, adherence to treatments for vulvovaginal atrophy was poor in 72.5% asked (n = 204). Reduced sexual activity (p > 0.001) and coronavirus diagnosis (p = 0.003) were significantly associated with poorer treatment compliance. Conclusions There is great lack of knowledge of the treatments used for GSM. Most women do not talk to their gynecologist about sexuality. Adherence to treatments during the coronavirus confinement has been worryingly low.Laura Baquedano MainarSonia Sánchez MéndezPeña Dieste PérezMónica Hernández AragónNicolás Mendoza Ladrón de Guevarathe COMEM Study Spanish investigatorsBMCarticleGenitourinary syndrome of menopauseKnowledgeMenopauseCOVID-19ConfinementAdherenceGynecology and obstetricsRG1-991Public aspects of medicineRA1-1270ENBMC Women's Health, Vol 21, Iss 1, Pp 1-6 (2021)
institution DOAJ
collection DOAJ
language EN
topic Genitourinary syndrome of menopause
Knowledge
Menopause
COVID-19
Confinement
Adherence
Gynecology and obstetrics
RG1-991
Public aspects of medicine
RA1-1270
spellingShingle Genitourinary syndrome of menopause
Knowledge
Menopause
COVID-19
Confinement
Adherence
Gynecology and obstetrics
RG1-991
Public aspects of medicine
RA1-1270
Laura Baquedano Mainar
Sonia Sánchez Méndez
Peña Dieste Pérez
Mónica Hernández Aragón
Nicolás Mendoza Ladrón de Guevara
the COMEM Study Spanish investigators
Women's knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the COVID-19 era in a sample of them: COMEM-GSM study
description Abstract Objective To study knowledge regarding genitourinary syndrome of menopause (GSM) and the treatments for it and to analyze treatment adherence during the COVID-19 confinement. Methods Multi-center observational study including women between 35 and 75 years. An extension study of treatment adherence was conducted during the coronavirus pandemic between March and April 2020. Results A sample of 2355 women were included. Vaginal dryness was the most frequently identified symptom (74.3%). Lubricants were the best-known treatments (69.6%), followed by local estrogens (25.7%); 66% of the women did not speak to their gynecologist about sexuality. Comparative analyses were conducted according to age, menopausal status, type of menopause, place of residence, type of health care received and level of education. During the coronavirus confinement period, adherence to treatments for vulvovaginal atrophy was poor in 72.5% asked (n = 204). Reduced sexual activity (p > 0.001) and coronavirus diagnosis (p = 0.003) were significantly associated with poorer treatment compliance. Conclusions There is great lack of knowledge of the treatments used for GSM. Most women do not talk to their gynecologist about sexuality. Adherence to treatments during the coronavirus confinement has been worryingly low.
format article
author Laura Baquedano Mainar
Sonia Sánchez Méndez
Peña Dieste Pérez
Mónica Hernández Aragón
Nicolás Mendoza Ladrón de Guevara
the COMEM Study Spanish investigators
author_facet Laura Baquedano Mainar
Sonia Sánchez Méndez
Peña Dieste Pérez
Mónica Hernández Aragón
Nicolás Mendoza Ladrón de Guevara
the COMEM Study Spanish investigators
author_sort Laura Baquedano Mainar
title Women's knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the COVID-19 era in a sample of them: COMEM-GSM study
title_short Women's knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the COVID-19 era in a sample of them: COMEM-GSM study
title_full Women's knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the COVID-19 era in a sample of them: COMEM-GSM study
title_fullStr Women's knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the COVID-19 era in a sample of them: COMEM-GSM study
title_full_unstemmed Women's knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the COVID-19 era in a sample of them: COMEM-GSM study
title_sort women's knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the covid-19 era in a sample of them: comem-gsm study
publisher BMC
publishDate 2021
url https://doaj.org/article/11e1ec07cc8c464f813bf3cdc08515c2
work_keys_str_mv AT laurabaquedanomainar womensknowledgeaboutthegenitourinarysyndromeofmenopauseadherencetoitstreatmentsinthecovid19erainasampleofthemcomemgsmstudy
AT soniasanchezmendez womensknowledgeaboutthegenitourinarysyndromeofmenopauseadherencetoitstreatmentsinthecovid19erainasampleofthemcomemgsmstudy
AT penadiesteperez womensknowledgeaboutthegenitourinarysyndromeofmenopauseadherencetoitstreatmentsinthecovid19erainasampleofthemcomemgsmstudy
AT monicahernandezaragon womensknowledgeaboutthegenitourinarysyndromeofmenopauseadherencetoitstreatmentsinthecovid19erainasampleofthemcomemgsmstudy
AT nicolasmendozaladrondeguevara womensknowledgeaboutthegenitourinarysyndromeofmenopauseadherencetoitstreatmentsinthecovid19erainasampleofthemcomemgsmstudy
AT thecomemstudyspanishinvestigators womensknowledgeaboutthegenitourinarysyndromeofmenopauseadherencetoitstreatmentsinthecovid19erainasampleofthemcomemgsmstudy
_version_ 1718372175483764736